Mesa Laboratories MLAB Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $3.73M+101% | -$1.57M+99.4% | -$620K+99.8% | -$1.97M+99.2% | ||
| $5.25M-2.4% | $5.34M-0.4% | $5.18M-2.8% | $5.38M+14.0% | $5.38M-53.0% | ||
| $17.87M+36.0% | $14.21M+11.1% | $14.07M+12.1% | $14.1M+18.5% | $13.14M+10.1% | ||
| —— | —— | —— | $2.97M— | $2.93M— | ||
| —— | —— | $2.86M+206% | $1.47M+147% | -$1.15M+55.0% | ||
| —— | —— | —— | —— | —— | ||
| $3.5M-63.2% | $6.1M+625% | $4.86M— | $4.97M— | $9.5M— | ||
| —— | -$5.17M— | -$6.04M— | -$5.61M— | -$4.95M— | ||
| —— | —— | —— | —— | —— | ||
| -$608K-22.1% | $1.52M+118% | -$47K+98.6% | $1.49M+167% | -$498K-136% | ||
| $18.02M-5.9% | $19.68M+9.5% | $19.62M-8.9% | $19.64M-18.8% | $19.15M-30.0% | ||
| $0-100% | $0-100% | $0-100% | $0-100% | $2.89M— | ||
| $42.83M-8.5% | $41.53M-11.7% | $40.91M+1.2% | $37.96M-15.5% | $46.81M+6.1% | ||
| $3.25M-23.5% | $3.59M-10.9% | $3.67M-15.5% | $4.37M+37.0% | $4.25M+65.5% | ||
| $0-100% | $62.5K-66.7% | $125K0.0% | $187.5K+200% | $250K— | ||
| -$3.25M+27.8% | -$3.84M-10.0% | -$3.92M+95.3% | -$4.62M+94.4% | -$4.5M+94.5% | ||
| $3.52M+1.6% | $3.51M+1.4% | $3.49M+1.1% | $3.48M+0.8% | $3.47M+0.6% | ||
| $36.75M-17.0% | $40M+5.8% | $40.75M+9.0% | $42.25M+20.9% | $44.25M+32.1% | ||
| -$41.85M+6.0% | -$42.29M— | -$42.79M— | -$43.52M— | -$44.51M— | ||
| $1.98M— | $2.72M— | —— | —— | —— | ||
| -$393K+56.0% | -$1.98M-173% | -$3.92M+65.3% | -$7.19M-84.2% | -$893K+81.0% | ||
| $18.02M-5.9% | $19.68M+9.5% | $19.62M-8.9% | $19.64M-18.8% | $19.15M-30.0% | ||
| $5.25M-2.4% | $5.34M-0.4% | $5.18M-2.8% | $5.38M+14.0% | $5.38M+27.1% | ||
| —— | —— | —— | —— | —— | ||
| -$608K-22.1% | $1.52M+118% | -$47K+98.6% | $1.49M+167% | -$498K-136% | ||
| —— | $3.73M+101% | -$1.57M+99.4% | -$620K+99.8% | -$1.97M+99.2% | ||
| —— | -$5.17M— | -$6.04M— | -$5.61M— | -$4.95M— | ||
| $0-100% | $62.5K-66.7% | $125K0.0% | $187.5K+200% | $250K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $36.75M-17.0% | $40M+5.8% | $40.75M+9.0% | $42.25M+20.9% | $44.25M+32.1% | ||
| $0— | —— | —— | —— | —— | ||
| $1.98M— | $2.72M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $9.56M— | $7.17M— | $4.78M— | $2.39M— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $39.58M-7.0% | $37.94M-11.8% | $37.24M+3.2% | $33.59M-19.5% | $42.56M+2.4% | ||
| $39.58M-7.0% | $37.94M-11.8% | $37.24M+3.2% | $33.59M-19.5% | $42.56M+2.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Mesa Laboratories generate?
- Mesa Laboratories (MLAB) generated $42.8M in operating cash flow over the trailing twelve months.
- What is Mesa Laboratories's free cash flow?
- After $3.3M of capital expenditures, Mesa Laboratories's free cash flow was $39.6M over the trailing twelve months, down 7.0% year over year.
- Where does Mesa Laboratories's cash flow data come from?
- Every line is extracted from Mesa Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
